Abstract
We provide evidence that cocaine evokes short- and long-lasting increases in activity-regulated cytoskeletal-associated protein (Arc) expression after a finely tuned, time-dependent and regional-selective expression profile. Acute experiments revealed that cocaine up-regulates Arc expression primarily in striatum and prefrontal cortex through a dopamine D1-dependent mechanism and a combination of D1- and D2-dependent mechanisms, respectively. Aside from cocaine-dependent Arc elevation, we show for the first time that D1 and D2 receptors tonically regulate basal Arc expression following a regional-selective profile. As opposed to the effects of a single cocaine injection on Arc expression, which dissipate within 24 h, subchronic (five daily injections) or chronic (14 daily injections) cocaine administration, with animals sacrificed hours or days after the last treatment, demonstrated that Arc expression is still up-regulated long after treatment cessation, suggesting that adaptive changes have been set in motion by the prolonged administration of the psychostimulant. In summary, our findings are the first to demonstrate that repeated exposure to cocaine leads to long-lasting dysregulation of Arc expression in the corticostriatal network, thus establishing a molecular basis to explain, at least partially, the impaired synaptic transmission caused by cocaine abuse at this level. Furthermore, given the role exerted by Arc in cytoarchitectural rearrangements, it is conceivable to speculate that it mediates changes in synaptic connectivity brought about by cocaine. Our findings thus pinpoint this molecule as a neuropathological underpinning and molecular bridge that connects short- and long-term neuronal modifications associated with cocaine abuse.
Footnotes
-
This work was supported by the Dipartimento Nazionale Politiche Antidroga, Presidenza del Consiglio dei Ministri (to G.R.). Other sources of funding came from the Ministry of University and Research (Fondo per gli Investimenti della Ricerca di Base 2001 to G.R.), the Ministry of University and Research (Programmi di Ricerca di Interesse Nazionale 2003 and 2005 to M.A.R.), and the Unversity of Milan (Fondo Interno Ricerca Scientifica e Tecnologica 2004 to F.F.).
-
This work was submitted to the American Society for Neuroscience as an abstract (Atlanta, Oct 14-18, 2006).
-
ABBREVIATIONS: IEG, immediate early gene; Arc, activity-regulated cytoskeletal-associated protein; SCH 23390, R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine; SKF 81297, (±)-6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ANOVA, analysis of variance.
- Received May 5, 2006.
- Accepted August 14, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|